Obstructive Sleep Apnea Clinical Trial
Official title:
RCT Study of Short-term Clinical Efficacy of High Flow Nasal Catheter Oxygen Therapy for Obstructive Sleep Apnea
NCT number | NCT05549245 |
Other study ID # | 2022038 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | August 20, 2022 |
Est. completion date | May 2023 |
Patients meeting the criteria of obstructive sleep apnea were included, and all patients signed informed consent, which met the requirements of the ethics Committee of our unit. All subjects were hospitalized patients. Subjects were randomly enrolled into High-flow Nasal Cannula Oxygen Therapy group or Continues Positive Airway Pressure group for 3 days of treatment. Sleep monitoring was performed on the first and fourth day of enrollment.
Status | Recruiting |
Enrollment | 194 |
Est. completion date | May 2023 |
Est. primary completion date | May 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility | Inclusion Criteria: 1. There were typical symptoms of sleep snoring at night with apnea and daytime sleepiness (ESS score =9). Stenosis and obstruction in any part of the upper airway were observed on physical examination, with AHI=5 times /h. 2. For patients with no significant daytime sleepiness (ESS score < 9), AHI=10 times /h. 3. Patients with AHI=5 times /h had one or more OSAHS complications, such as cognitive impairment, hypertension, coronary heart disease, cerebrovascular disease, diabetes and insomnia. Exclusion Criteria: 1. Patients who cannot tolerate non-invasive ventilator or transnasal high-flow oxygen therapy. 2. Ongoing treatment may affect sleep, such as sedatives, hypnotics, muscle relaxants, etc. 3. Hemodynamic instability. 4. Severe respiratory diseases. |
Country | Name | City | State |
---|---|---|---|
China | Qilu Hospital of Shandong University | Jinan | Shandong |
Lead Sponsor | Collaborator |
---|---|
Qilu Hospital of Shandong University |
China,
Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ, Nunez CM, Patel SR, Penzel T, Pépin JL, Peppard PE, Sinha S, Tufik S, Valentine K, Malhotra A. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019 Aug;7(8):687-698. doi: 10.1016/S2213-2600(19)30198-5. Epub 2019 Jul 9. Review. — View Citation
Jordan AS, McSharry DG, Malhotra A. Adult obstructive sleep apnoea. Lancet. 2014 Feb 22;383(9918):736-47. doi: 10.1016/S0140-6736(13)60734-5. Epub 2013 Aug 2. Review. — View Citation
Nakanishi N, Suzuki Y, Ishihara M, Ueno Y, Tane N, Tsunano Y, Itagaki T, Oto J. Effect of High-Flow Nasal Cannula on Sleep-disordered Breathing and Sleep Quality in Patients With Acute Stroke. Cureus. 2020 Jul 20;12(7):e9303. doi: 10.7759/cureus.9303. — View Citation
Nilius G, Wessendorf T, Maurer J, Stoohs R, Patil SP, Schubert N, Schneider H. Predictors for treating obstructive sleep apnea with an open nasal cannula system (transnasal insufflation). Chest. 2010 Mar;137(3):521-8. doi: 10.1378/chest.09-0357. Epub 2009 Dec 1. — View Citation
Parke RL, McGuinness SP. Pressures delivered by nasal high flow oxygen during all phases of the respiratory cycle. Respir Care. 2013 Oct;58(10):1621-4. doi: 10.4187/respcare.02358. Epub 2013 Mar 19. — View Citation
Yan H, Qinghua L, Mengyuan P, Yaoyu C, Long Z, Mengjie L, Xiaosong D, Fang H. High flow nasal cannula therapy for obstructive sleep apnea in adults. Sleep Breath. 2022 Jun;26(2):783-791. doi: 10.1007/s11325-021-02453-6. Epub 2021 Aug 12. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | AHI | Apnea Hypopnea Index:The number of episodes of sleep apnea per hour | The first day of enrollment | |
Primary | AHI | Apnea Hypopnea Index:The number of episodes of sleep apnea per hour | The fourth day of enrollment | |
Primary | Treatment failure rate | Number of patients unable to tolerate treatment/enrollment | The fourth day of enrollment | |
Primary | Good compliance rate | Number of patients treated for more than 4 hours per night/enrolled | The fourth day of enrollment | |
Primary | longest apnea time | Maximum duration(s) of nocturnal sleep apnea in patients | The first day of enrollment | |
Primary | longest apnea time | Maximum duration(s) of nocturnal sleep apnea in patients | The fourth day of enrollment | |
Primary | Mean oxygen saturation | Mean oxygen saturation during the patient's night sleep | The first day of enrollment | |
Primary | Mean oxygen saturation | Mean oxygen saturation during the patient's night sleep | The fourth day of enrollment | |
Primary | minimum oxygen saturation | Lowest oxygen saturation during the patient's night sleep | The first day of enrollment | |
Primary | minimum oxygen saturation | Lowest oxygen saturation during the patient's night sleep | The fourth day of enrollment | |
Secondary | Gender | Male and female | The first day of enrollment | |
Secondary | height | Height (in cm) | The first day of enrollment | |
Secondary | age | years | The first day of enrollment | |
Secondary | weight | Kg | The first day of enrollment | |
Secondary | total sleep time | Total sleep duration(min) of the patient at night | The first day of enrollment | |
Secondary | total sleep time | Total sleep duration(min) of the patient at night | The fourth day of enrollment | |
Secondary | Number of awakening | The number of awakenings during the patient's night sleep | The first day of enrollment | |
Secondary | Number of awakening | The number of awakenings during the patient's night sleep | The fourth day of enrollment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05857384 -
Bioavailability, Bioequivalence and Tolerability of IHL-42X Compared to the Reference Drugs
|
Phase 1 | |
Recruiting |
NCT04547543 -
Follow-up of Apneic Patients by Visio-consultation
|
N/A | |
Recruiting |
NCT05371509 -
Novel Myofunctional Water Bottle to Reduce OSA and Snoring Study
|
N/A | |
Completed |
NCT02515357 -
Mediterranean Diet/Lifestyle Intervention in Obstructive Sleep Apnea
|
N/A | |
Completed |
NCT05582070 -
Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction
|
N/A | |
Active, not recruiting |
NCT03189173 -
Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea
|
Phase 2 | |
Completed |
NCT04084899 -
The Effect of CPAP on Lung Hyperinflation in Patients With OSA
|
||
Completed |
NCT03032029 -
Registry on the Treatment of Central and Complex Sleep-Disordered Breathing With Adaptive Servo-Ventilation
|
||
Recruiting |
NCT04028011 -
Clinical Evaluation of a Wearable Technology for the Diagnosis of Sleep Apnoea
|
||
Recruiting |
NCT06047353 -
Community Health Advocates for Motivating PAP Use in Our Neighborhoods.
|
N/A | |
Completed |
NCT05253963 -
Acute Effect of CPAP on Weight in Patients With Obstructive Sleep Apnea
|
N/A | |
Recruiting |
NCT06029959 -
Stroke and CPAP Outcome Study 3
|
N/A | |
Recruiting |
NCT06150352 -
Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
|
||
Completed |
NCT03589417 -
Postural Stability, Balance and Fall Risk in Patients With Obstructive Sleep Apnea
|
||
Recruiting |
NCT04335994 -
ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing
|
N/A | |
Withdrawn |
NCT04063436 -
Evaluation of a New Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea
|
N/A | |
Recruiting |
NCT05385302 -
Sociological Determinants of Positive Airway Pressure Adherence in OSA Patients
|
||
Recruiting |
NCT04572269 -
Metabolomics of Obstructive Sleep Apnea
|
||
Not yet recruiting |
NCT06467682 -
12-week Tele-exercise Program in Patients With OSA
|
N/A | |
Withdrawn |
NCT04011358 -
Retinal Vein Occlusion and Obstructive Sleep Apnea: A Case Control Study
|
N/A |